¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2022 ´ëÇѺñ¸¸ÇÐȸ Á¦55Â÷ Ãá°èÇмú´ëȸ : 2022-03-12

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2022 ´ëÇѺñ¸¸ÇÐȸ Á¦55Â÷ Ãá°èÇмú´ëȸ : 2022-03-12
±³À°ÀÏÀÚ : 2022-03-12
±³À°Àå¼Ò : ¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ µ¿½Ã °³ÃÖ (*¿ÀÇÁ¶óÀÎ: ±×·£µå ¿öÄ¿Èú ¼­¿ï)  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) 2022 ´ëÇѺñ¸¸ÇÐȸ Á¦55Â÷ Ãá°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѺñ¸¸ÇÐȸ
´ã´çÀÚ : °­¶ó¿µ
¿¬¶ôó : 02-6941-0888  
À̸ÞÀÏ : obesity@kosso.or.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, °¡Á¤ÀÇÇаú
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 21 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 70,000¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-12 Room 1 08:00~08:50 ºñ¸¸È¯ÀÚ¿¡¼­ÀÇ ¸®³ª±Û¸³Æ¾  ÇѺ´´ö(°í·ÁÀÇ´ë ¾È¾Ïº´¿ø °¡Á¤ÀÇÇаú) 
±³À°½Ã°£ 03-12 Room 2 08:00~08:50 ºñ¸¸È¯ÀÚ¿¡¼­ÀÇ ´ç´¢º´¾à¹° ¼±Åà ¼ÕÀå¿ø(°¡Å縯ÀÇ´ë ºÎõ¼º¸ðº´¿ø ³»ºÐºñ³»°ú) 
±³À°½Ã°£ 03-12 Room 1 09:00~09:20 Clinical research data of Tirzepatide and Semaglutide  Á¤Ã¢Èñ(¿ï»êÀÇ´ë ³»°ú) 
±³À°½Ã°£ 03-12 Room 1 09:20~09:40 Combination therapy of anti-diabetic and anti-obesity agents  È«ÁØÈ­(À»ÁöÀÇ´ë ³»ºÐºñ³»°ú) 
±³À°½Ã°£ 03-12 Room 1 09:40~10:00 Upcoming novel combinations of anti-obesity therapeutics  ÀüÀçÇÑ(°æºÏÀÇ´ë ³»°ú) 
Åä·Ð 03-12 Room 1 10:00~10:20 ÆгÎÅäÀÇ  ¹®Áؼº, À±Áö¿Ï(¿µ³²ÀÇ´ë ³»°ú, ¼­¿ïÀÇ´ë ³»ºÐºñ³»°ú) 
±³À°½Ã°£ 03-12 Room 2 09:00~09:20 Hypothalamic inflammation in the control of metabolic function  ±è¹Î¼ö(KIST) 
±³À°½Ã°£ 03-12 Room 2 09:20~09:40 ºñ¸¸ °ü·Ã È£¸£¸ó  Á¤¿ëÅÃ(°í·Á´ë) 
±³À°½Ã°£ 03-12 Room 2 09:40~10:00 Dopaminergic control of food intake: Role of dopamine D2 receptor  ¹éÀÚÇö(°í·Á´ë) 
Åä·Ð 03-12 Room 2 10:00~10:20 ÆгÎÅäÀÇ  ±è¿øÁØ(°­¸ª¾Æ»êº´¿ø) 
±³À°½Ã°£ 03-12 Room 3 09:00~09:20 Live imaging of peripheral taste sensation  ÃÖ¸íȯ(¼­¿ï´ëÇб³ »ý¸í°úÇкÎ) 
±³À°½Ã°£ 03-12 Room 3 09:20~09:40 History and types of alternative sweeteners  À¯»óÈ£(¼¼Á¾´ëÇб³ ½ÄÇ°°øÇаú) 
±³À°½Ã°£ 03-12 Room 3 09:40~10:00 Application of alternative sweeteners in diet management of chronic disease  ÀÌÇý¿Á(±¹¸³Áß¾ÓÀÇ·á¿ø ÀÓ»ó¿µ¾çÆÀ) 
Åä·Ð 03-12 Room 3 10:00~10:20 ÆгÎÅäÀÇ  ÀÓÇöÁ¤, ÀÌÀºÁ¤(°æÈñ´ë ½ÄÇ°¿µ¾çÇаú, ¼º±Õ°üÀÇ´ë °­ºÏ»ï¼ºº´¿ø ³»ºÐºñ³»°ú) 
±³À°½Ã°£ 03-12 Room 1 10:30~11:30 Comprehensive Perspective on Obesity in Koreans  ¹ÚÇý¼ø(¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø °¡Á¤ÀÇÇаú) 
±³À°½Ã°£ 03-12 Room 1 11:30~12:30 ½ºÅ¸Æ¾, ¿¡Á¦Æ¼¹Ìºê º¹ÇÕÁ¦ÀÇ ÃֽŠ°æÇâ  ÇѺ´´ö(°í·ÁÀÇ´ë ¾È¾Ïº´¿ø °¡Á¤ÀÇÇаú) 
±³À°½Ã°£ 03-12 Room 1 12:30~12:45 ºñ¸¸ÀÇ Áø´Ü  ±è¾çÇö(°í·ÁÀÇ´ë °¡Á¤ÀÇÇаú) 
±³À°½Ã°£ 03-12 Room 1 12:45~13:00 Ã¼Áß°¨·® ÈÄ À¯Áö  È«ÁØÈ­(À»ÁöÀÇ´ë ³»ºÐºñ³»°ú) 
±³À°½Ã°£ 03-12 Room 1 13:00~13:15 Á¤½Å°ú ÁúȯÀÌ µ¿¹ÝµÈ ºñ¸¸È¯ÀÚ  ±è½ÂÁØ(°Ç¾çÀÇ´ë Á¤½Å°Ç°­ÀÇÇаú) 
Åä·Ð 03-12 Room 1 13:15~13:50 ÆгÎÅäÀÇ  ±è¼º¼ö, ±èÁ¾È­, ±è°æ°ï, ±Ç´ëÀÍ, Á¤Áö¿¬(Ãæ³²ÀÇ´ë °¡Á¤ÀÇÇаú, ¼¼Á¾º´¿ø ³»ºÐºñ³»°ú, °¡ÃµÀÇ´ë °¡Á¤ÀÇÇаú, Çѱ¹ÀϺ¸, Çѱ¹¼ÒºñÀÚ¿¬¸Í »ç¹«ÃÑÀå) 
±³À°½Ã°£ 03-12 Room 2 12:30~14:00 Oral Presentation 2  ÀÓ¼ö(¼­¿ïÀÇ´ë ºÐ´ç¼­¿ï´ëº´¿ø ³»ºÐºñ³»°ú) 
±³À°½Ã°£ 03-12 Room 3 12:30~14:00 Oral Presentation 3  ¼ÕÀå¿ø(°¡Å縯ÀÇ´ë ºÎõ¼º¸ðº´¿ø ³»ºÐºñ³»°ú) 
±³À°½Ã°£ 03-12 Room 1 14:00~14:20 Introduction of MAFLD  ±¸º¸°æ(¼­¿ïÀÇ´ë ³»ºÐºñ³»°ú) 
±³À°½Ã°£ 03-12 Room 1 14:20~14:40 Current treatment option  ÀÌ¿ëÈ£(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 03-12 Room 1 14:40~15:00 new target  Àü´ë¿ø(ÇѾçÀÇ´ë ¼ÒÈ­±â³»°ú) 
Åä·Ð 03-12 Room 1 15:00~15:20 ÆгÎÅäÀÇ  À̽Âȯ, ¿À¹üÁ¶(¼­¿ï¼º¸ðº´¿ø, ¼­¿ïÀÇ´ë º¸¶ó¸Åº´¿ø) 
±³À°½Ã°£ 03-12 Room 2 14:00~14:20 ºñ¸¸ ±âÃÊ °­ÀÇ1  ±èÀç¹ü(¼­¿ï´ë »ý¸í°úÇкÎ) 
±³À°½Ã°£ 03-12 Room 2 14:20~14:40 Organ crosstalk to control metabolic homeostasis: from intestine to adipose tissue  È²¼º¼ø(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 03-12 Room 2 14:40~15:00 ºñ¸¸ ±âÃÊ °­ÀÇ2  ¼­Àç¸í(Ä«À̽ºÆ® ÀÇ°úÇдëÇпø) 
Åä·Ð 03-12 Room 2 15:00~15:20 ÆгÎÅäÀÇ  ÀÌÀ±Èñ, ¹ÚŽÄ(¼­¿ï´ë ¾à´ë ºÎ±³¼ö, °¡Ãµ´ë »ý¸í°úÇаú) 
±³À°½Ã°£ 03-12 Room 3 14:00~14:20 ¼Ò¾Æû¼Ò³â °íµµºñ¸¸ÀÇ ¿µ¾ç¿ä¹ý  ÀÓÇöÁ¤(°æÈñ´ëÇб³ ÀÇÇпµ¾çÇаú) 
±³À°½Ã°£ 03-12 Room 3 14:20~14:40 ¼Ò¾Æû¼Ò³â °íµµºñ¸¸ÀÇ ¾à¹°Ä¡·á  Á¤Çý¿î(°æÈñÀÇ´ë ¼Ò¾Æû¼Ò³â°ú) 
±³À°½Ã°£ 03-12 Room 3 14:40~15:00 ¼Ò¾Æû¼Ò³â °íµµºñ¸¸ÀÇ ¼ö¼úÄ¡·á  ¹Ú¿µ¼®(¼­¿ïÀÇ´ë ºñ¸¸´ë»ç¿Ü°ú) 
Åä·Ð 03-12 Room 3 15:00~15:20 ÆгÎÅäÀÇ  ÀÌ¿µÁØ, ±èÀçÇö(°í·ÁÀÇ´ë ¾È»êº´¿ø ¼Ò¾Æû¼Ò³â°ú, ºÐ´ç¼­¿ï´ëº´¿ø ¼Ò¾Æû¼Ò³â°ú) 
±³À°½Ã°£ 03-12 Room 1 15:30~16:00 ´ç´¢º´ ¿¹¹æ  ±ÇÇõ»ó(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 03-12 Room 2 15:30~16:00 ºòµ¥ÀÌÅÍ¿¬±¸  ÇÑ°æµµ(¼þ½Ç´ë) 
±³À°½Ã°£ 03-12 Room 3 15:30~16:00 ºñ¸¸½Ä»ç¿ä¹ýÀÇ Ã¼°èÀû ¹®Çå°íÂû°ú ´ÙÇÐÁ¦ ±Ç°í¾È  ±è°æ°ï(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 03-12 Room 1 16:00~16:20 Obesity and sleep  ±èÁø¿í(À»ÁöÀÇ´ë °¡Á¤ÀÇÇаú) 
±³À°½Ã°£ 03-12 Room 1 16:20~16:40 Obesity and cancer  °íÇýÁø(°æºÏÀÇ´ë °¡Á¤ÀÇÇаú) 
±³À°½Ã°£ 03-12 Room 1 16:40~17:00 Obesity and cognitive function  Á¤ÁöÇâ(ÀÌÈ­ÀÇ´ë ½Å°æ°ú) 
Åä·Ð 03-12 Room 1 17:00~17:20 ÆгÎÅäÀÇ  ¹Ú°æÈñ, ȲÀ¯Ã¶(ÇѸ²ÀÇ´ë °¡Á¤ÀÇÇаú, °æÈñÀÇ´ë °­µ¿°æÈñ´ëº´¿ø ³»ºÐºñ³»°ú) 
±³À°½Ã°£ 03-12 Room 2 16:00~16:20 ºñ¸¸°ú °Ç°­¼ö¸í, ±â´ë¿©¸í  ¼ÕÀå¿ø(°¡Å縯ÀÇ´ë ³»ºÐºñ³»°ú) 
±³À°½Ã°£ 03-12 Room 2 16:20~16:40 ºñ¸¸´ë»çÁúȯ¿¡¼­ÀÇ µðÁöÅÐÄ¡·áÁ¦ÀÇ ÀÓ»óÀû È°¿ë  ÇѺ´´ö(°í·ÁÀÇ´ë °¡Á¤ÀÇÇаú) 
±³À°½Ã°£ 03-12 Room 2 16:40~17:00 ºñ¸¸°ú ÀÎÁö±â´É ÀúÇÏ ¹× Ä¡¸Å  ³²°¡Àº(°í·ÁÀÇ´ë °¡Á¤ÀÇÇаú) 
Åä·Ð 03-12 Room 2 17:00~17:20 ÆгÎÅäÀÇ  ÀÌ»ó¿­, ÀÌÀçÇõ(°æÈñÀÇ´ë °æÈñ´ëº´¿ø ³»ºÐºñ´ë»ç³»°ú, ÇѾç´ë ¸íÁöº´¿ø ³»ºÐºñ³»°ú) 
±³À°½Ã°£ 03-12 Room 3 16:00~16:20 Lactate acts as an anti-obesity metabolite through acceleration of lipid metabolism  °íÁøÈ£(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 03-12 Room 3 16:20~16:40 The identification of exercise-induced genes encoding secretory peptides in the young and the elderly  ·ùµ¿·Ä(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 03-12 Room 3 16:40~17:00 Role of fitness in the metabolically healthy obesity  Á¦¼¼¿µ(¼­¿ï½Ã¸³´ëÇб³) 
Åä·Ð 03-12 Room 3 17:00~17:20 ÆгÎÅäÀÇ  ±èÁ¾Èñ, À̼¼¿ø(ÇѾç´ë üÀ°Çаú, ÀÎõ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2022 ´ëÇѺñ¸¸ÇÐȸ Á¦55Â÷ Ãá°èÇмú´ëȸ : 2022-03-12""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÁ·ºÎÁ·°üÀýÇÐȸ 2022³â Total Ankle Arthroplasty (TAA) Çмú´ëȸ (ÇÏÀ̺긮µå) : 2022-03-12
´ÙÀ½±Û Á¦8ȸ ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ Áú°ü¸® ½ÉÆ÷Áö¿ò : 2022-03-12
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 33 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 33 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 30 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 25 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 29 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 38 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 17 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 23 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 22 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 20 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 21 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 19 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 22 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 23 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 25 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷